Bradley L. Campbell - 15 Mar 2022 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chief Operating Officer, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
15 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Apr 2022, 19:31:42 UTC
Previous filing
19 Jan 2022
Next filing
22 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Award +104,603 +18% 689,618 15 Mar 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +187,970 $0.000000 187,970 15 Mar 2022 Common Stock 187,970 $8.95 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.
F2 The Restricted Stock Units will vest in four equal annual installments beginning on March 15, 2023.
F3 These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.

Remarks:

These equity awards represent Mr. Campbell's promotional grant as previously disclosed on the Form 8-K filed with the SEC on February 24, 2022.